Altered immunometabolism at the interface of increased endoplasmic reticulum (ER) stress in patients with type 2 diabetes

Journal of Leukocyte Biology

Volumn 98, Issue 4, 2015, Pages 615-621

  Lenin, Raji ^a   Sankaramoorthy, Aravind ^a   Mohan, Viswanathan ^a   Balasubramanyam, Muthuswamy ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Apoptosis; Inflammation; miR 146a; PBMCs; UPR

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; CASPASE 3; CHOLESTEROL; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INOSITOL REQUIRING ENZYME 1ALPHA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MICRORNA 146A; PERK PROTEIN; PROTEIN; PROTEIN P22; SUPPRESSOR OF CYTOKINE SIGNALING 3; THIOREDOXIN INTERACTING PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; BIOLOGICAL MARKER; CYTOKINE; MICRORNA; MIRN146 MICRORNA, HUMAN;

ADULT; APOPTOSIS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; IMMUNOPRECIPITATION; MIDDLE AGED; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; BIOMARKERS; CYTOKINES; DIABETES MELLITUS, TYPE 2; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMANS; IMMUNOPRECIPITATION; MALE; MICRORNAS; MIDDLE AGED; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84943166086     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A1214-609R     Document Type: Article

References (53)

1. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A. H., Iwakoshi, N. N., Ozdelen, E., Tuncman, G., G örg ün, C., Glimcher, L. H., Hotamisligil, G. S. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461
2. Peter, A., Weigert, C., Staiger, H., Machicao, F., Schick, F., Machann, J., Stefan, N., Thamer, C., Häring, H. U., Schleicher, E. (2009) Individual stearoyl-CoA desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58, 1757-1765
3. Hetz, C. (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89-102
4. Staimez, L. R., Weber, M. B., Ranjani, H., Ali, M. K., Echouffo-Tcheugui, J. B., Phillips, L. S., Mohan, V., Narayan, K. M. (2013) Evidence of reduced b-cell function in Asian Indians with mild dysglycemia. Diabetes Care 36, 2772-2778
5. Hotamisligil, G. S. (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917
6. Balasubramanyam, M., Lenin, R., Monickaraj, F. (2010) Endoplasmic reticulum stress in diabetes: new insights of clinical relevance. Indian J. Clin. Biochem. 25, 111-118
7. Sundar Rajan, S., Srinivasan, V., Balasubramanyam, M., Tatu, U. (2007) Endoplasmic reticulum (ER) stress & diabetes. Indian J. Med. Res. 125, 411-424
8. Sampathkumar, R., Balasubramanyam, M., Sudarslal, S., Rema, M., Mohan, V., Balaram, P. (2005) Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin. Biochem. 38, 892-899
9. Adaikalakoteswari, A., Balasubramanyam, M., Rema, M., Mohan, V. (2006) Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with type 2 diabetes and microangiopathy. Diabet. Med. 23, 666-674
10. Adaikalakoteswari, A., Rema, M., Mohan, V., Balasubramanyam, M. (2007) Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. Int. J. Biochem. Cell Biol. 39, 1673-1684
11. Srinivasan, V., Sandhya, N., Sampathkumar, R., Farooq, S., Mohan, V., Balasubramanyam, M. (2007) Glutamine fructose-6-phosphate amidotransferase (GFAT) gene expression and activity in patients with type 2 diabetes: inter-relationships with hyperglycaemia and oxidative stress. Clin. Biochem. 40, 952-957
12. Gokulakrishnan, K., Deepa, R., Mohan, V. (2008) Association of high sensitivity C-reactive protein (hsCRP) and tumour necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES-31). Clin. Biochem. 41, 480-485
13. Gokulakrishnan, K., Mohanavalli, K. T., Monickaraj, F., Mohan, V., Balasubramanyam, M. (2009) Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and type 2 diabetes patients. Mol. Cell. Biochem. 324, 173-181
14. Indulekha, K., Surendar, J., Anjana, R. M., Gokulakrishnan, K., Balasubramanyam, M., Aravindhan, V., Mohan, V. (2012) Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress and inflammation in Asian Indians. Dis. Markers 33, 185-192
15. Balasubramanyam, M., Aravind, S., Gokulakrishnan, K., Prabu, P., Sathishkumar, C., Ranjani, H., Mohan, V. (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol. Cell. Biochem. 351, 197-205
16. Iwasaki, Y., Suganami, T., Hachiya, R., Shirakawa, I., Kim-Saijo, M., Tanaka, M., Hamaguchi, M., Takai-Igarashi, T., Nakai, M., Miyamoto, Y., Ogawa, Y. (2014) Activating transcription factor 4 links metabolic stress to interleukin-6 expression in macrophages. Diabetes 63, 152-161
17. Sharp, P. S., Mohan, V., Levy, J. C., Mather, H. M., Kohner, E. M. (1987) Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm. Metab. Res. 19, 84-85
18. Alberti, K. G., Zimmet, P. Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539-553
19. Lenin, R., Maria, M. S., Agrawal, M., Balasubramanyam, J., Mohan, V., Balasubramanyam, M. (2012) Amelioration of glucolipotoxicity-induced endoplasmic reticulum stress by a “chemical chaperone” in human THP- 1 monocytes. Exp. Diabetes Res. 2012, 356487
20. Van Schadewijk, A., van’t Wout, E. F., Stolk, J., Hiemstra, P. S. (2012) A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress. Cell Stress Chaperones 17, 275-279
21. Wellen, K. E., Hotamisligil, G. S. (2005) Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119
22. Cnop, M., Foufelle, F., Velloso, L. A. (2012) Endoplasmic reticulum stress, obesity and diabetes. Trends Mol. Med. 18, 59-68
23. Komura, T., Sakai, Y., Honda, M., Takamura, T., Matsushima, K., Kaneko, S. (2010) CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes. Diabetes 59, 634-643
24. Sage, A. T., Holtby-Ottenhof, S., Shi, Y., Damjanovic, S., Sharma, A. M., Werstuck, G. H. (2012) Metabolic syndrome and acute hyperglycemia are associated with endoplasmic reticulum stress in human mononuclear cells. Obesity (Silver Spring) 20, 748-755
25. Liong, S., Lappas, M. (2015) Endoplasmic reticulum stress is increased in adipose tissue of women with gestational diabetes. PLoS ONE 10, e0122633
26. Chen, H., Qi, L. (2010) SUMO modification regulates the transcriptional activity of XBP1. Biochem. J. 429, 95-102
27. Wang, F. M., Chen, Y. J., Ouyang, H. J. (2011) Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation. Biochem. J. 433, 245-252
28. Huang, C. J., Lin, C. Y., Haataja, L., Gurlo, T., Butler, A. E., Rizza, R. A., Butler, P. C. (2007) High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56, 2016-2027
29. Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., Butler, P. C. (2003) b-Cell deficit and increased b-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110
30. Clark, A., Wells, C. A., Buley, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J., Holman, R. R., Turner, R. C. (1988) Islet amyloid, increased a-cells, reduced b-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 9, 151-159
31. Kl öppel, G., Löhr, M., Habich, K., Oberholzer, M., Heitz, P. U. (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv. Synth. Pathol. Res. 4, 110-125
32. Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., Yagihashi, S. (2002) Reduced b-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45, 85-96
33. Laybutt, D. R., Preston, A. M., Akerfeldt, M. C., Kench, J. G., Busch, A. K., Biankin, A. V., Biden, T. J. (2007) Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50, 752-763
34. Xu, C., Bailly-Maitre, B., Reed, J. C. (2005) Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115, 2656-2664
35. Szegezdi, E., Logue, S. E., Gorman, A. M., Samali, A. (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 7, 880-885
36. Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E., Mori, M. (2002) Targeted disruption of the CHOP gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 109, 525-532
37. Tabas, I., Ron, D. (2011) Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184-190
38. Balasubramanyam, M., Balaji, R. A., Subashini, B., Mohan, V. (2001) Evidence for mechanistic alterations of Ca2+ homeostasis in type 2 diabetes mellitus. Int. J. Exp. Diabetes Res. 1, 275-287
39. Zhu, Z., Luo, Z., Ma, S., Liu, D. (2011) TRP channels and their implications in metabolic diseases. Pflugers Arch. 461, 211-223
40. Yoshida, I., Monji, A., Tashiro, K., Nakamura, K., Inoue, R., Kanba, S. (2006) Depletion of intracellular Ca2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells. Neurochem. Int. 48, 696-702
41. Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O’Neill, M. C., Zinman, B., Viberti, G.; ADOPT Study Group. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355, 2427-2443
42. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., Spiegelman, B. M. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668
43. Taganov, K. D., Boldin, M. P., Chang, K. J., Baltimore, D. (2006) NF- kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486
44. Bartoszewski, R., Brewer, J. W., Rab, A., Crossman, D. K., Bartoszewska, S., Kapoor, N., Fuller, C., Collawn, J. F., Bebok, Z. (2011) The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J. Biol. Chem. 286, 41862-41870
45. Behrman, S., Acosta-Alvear, D., Walter, P. (2011) A CHOP-regulated microRNA controls rhodopsin expression. J. Cell Biol. 192, 919-927
46. Oslowski, C. M., Hara, T., O’Sullivan-Murphy, B., Kanekura, K., Lu, S., Hara, M., Ishigaki, S., Zhu, L. J., Hayashi, E., Hui, S. T., Greiner, D., Kaufman, R. J., Bortell, R., Urano, F. (2012) Thioredoxin-interacting protein mediates ER stress-induced b cell death through initiation of the inflammasome. Cell Metab. 16, 265-273
47. Lerner, A. G., Upton, J. P., Praveen, P. V., Ghosh, R., Nakagawa, Y., Igbaria, A., Shen, S., Nguyen, V., Backes, B. J., Heiman, M., Heintz, N., Greengard, P., Hui, S., Tang, Q., Trusina, A., Oakes, S. A., Papa, F. R. (2012) IRE1a induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab. 16, 250-264
48. Sun, X., Yu, W., Hu, C. (2014) Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application. Biomed Res. Int. 2014, 926713
49. Mohan, V., Amutha, A., Ranjani, H., Unnikrishnan, R., Datta, M., Anjana, R. M., Staimez, L., Ali, M. K., Narayan, K. M. (2013) Associations of b-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians. Diabetes Technol. Ther. 15, 315-322
50. Tersey, S. A., Nishiki, Y., Templin, A. T., Cabrera, S. M., Stull, N. D., Colvin, S. C., Evans-Molina, C., Rickus, J. L., Maier, B., Mirmira, R. G. (2012) Islet b-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61, 818-827
51. Cao, S. S., Kaufman, R. J. (2013) Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin. Ther. Targets 17, 437-448
52. Sun, J., Cui, J., He, Q., Chen, Z., Arvan, P., Liu, M. (2015) Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes. Mol. Aspects Med. 42, 105-118
53. Owens, D. R. (2013) Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol. Ther. 15, 776-785